Berman Michael A 4
4 · CADENCE PHARMACEUTICALS INC · Filed Jun 14, 2012
Insider Transaction Report
Form 4
Berman Michael A
Director
Transactions
- Award
Stock option (right to buy)
2012-06-13+17,500→ 17,500 totalExercise: $2.98Exp: 2022-06-13→ Common Stock (17,500 underlying)
Footnotes (1)
- [F1]Shares shall vest in twelve equal monthly installments of 1/12 of the original number of shares subject to such option beginning upon the Vesting Commencement Date of July 1, 2012, subject to such individual's continuing service on the Board through each such date.